Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Mirum Pharmaceuticals, Inc. (MIRM)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 53,602,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Mirum Pharmaceuticals is a biopharmaceutical company focused on the identification, acquisition, development and commercialization of therapies for rare and orphan diseases. Co.'s focus is the development and commercialization of LIVMARLI® (maralixibat) oral solution (Livmarli) and volixibat. Livmarli is an oral solution approved as a once daily medicine for cholestatic pruritus in patients with Alagille syndrome one year of age and older. Co.'s second product candidate, volixibat, an oral, minimally-absorbed agent designed to inhibit ileal bile acid transporter, for the treatment of adult patients with cholestatic liver diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 4,000 4,000 175,963 175,963
Total Buy Value $101,200 $101,200 $4,703,025 $4,703,025
Total People Bought 1 1 2 2
Total Buy Transactions 2 2 8 8
Total Shares Sold 4,303 26,974 69,916 431,922
Total Sell Value $111,017 $737,972 $1,983,116 $9,495,201
Total People Sold 1 5 6 8
Total Sell Transactions 1 12 21 30
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 191
  Page 5 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Longpre Lara Chief Development Officer   •       –      –    2021-11-10 4 A $13.52 $10,177 D/D 753 84,998     -
   Peetz Christopher President and CEO   •       •      –    2021-10-01 4 S $19.26 $70,708 D/D (3,672) 21,027     -
   Vig Pamela Chief Scientific Officer   •       –      –    2021-10-01 4 S $19.26 $26,265 D/D (1,364) 9,667     -
   Radovich Peter Chief Operating Officer   •       –      –    2021-10-01 4 S $19.26 $26,265 D/D (1,364) 11,273     -
   Clements Ian Chief Financial Officer   •       –      –    2021-10-01 4 S $19.26 $30,309 D/D (1,574) 16,653     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2021-10-01 4 S $19.26 $26,265 D/D (1,364) 45,768     -
   Longpre Lara Chief Development Officer   •       –      –    2021-10-01 4 S $19.26 $18,505 D/D (961) 84,245     -
   Peetz Christopher President and CEO   •       •      –    2021-09-29 4 A $0.00 $0 D/D 21,875 24,699     -
   Vig Pamela Chief Scientific Officer   •       –      –    2021-09-29 4 A $0.00 $0 D/D 8,125 11,031     -
   Radovich Peter Chief Operating Officer   •       –      –    2021-09-29 4 A $0.00 $0 D/D 8,125 12,637     -
   Clements Ian Chief Financial Officer   •       –      –    2021-09-29 4 A $0.00 $0 D/D 9,375 18,227     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2021-09-29 4 A $0.00 $0 D/D 8,125 47,132     -
   Longpre Lara Chief Development Officer   •       –      –    2021-09-29 4 A $0.00 $0 D/D 8,125 85,206     -
   Deerfield Special Situations Fund, L.p. * Possible Member of 10% Group   –       –       •   2021-07-09 4 S $15.81 $1,570,328 I/I (99,325) 0     -
   Deerfield Special Situations Fund, L.p. * Possible Member of 10% Group   –       –       •   2021-07-07 4 S $15.87 $108,496 I/I (6,837) 99,325     -
   Deerfield Special Situations Fund, L.p. * Possible Member of 10% Group   –       –       •   2021-07-06 4 S $16.20 $797,426 I/I (49,239) 106,162     -
   Deerfield Special Situations Fund, L.p. * Possible Member of 10% Group   –       –       •   2021-07-02 4 S $17.01 $180,300 I/I (10,599) 155,401     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2021-05-10 4 A $14.62 $21,681 D/D 1,483 39,007     -
   Vig Pamela Chief Scientific Officer   •       –      –    2021-05-10 4 A $14.62 $10,219 D/D 699 2,906     -
   Clements Ian Chief Financial Officer   •       –      –    2021-05-10 4 A $14.62 $14,342 D/D 981 8,852     -
   Radovich Peter Chief Operating Officer   •       –      –    2021-05-10 4 A $14.62 $14,708 D/D 1,006 4,512     -
   Longpre Lara Chief Development Officer   •       –      –    2021-05-10 4 A $14.62 $18,407 D/D 1,259 77,081     -
   Peetz Christopher President and CEO   •       •      –    2021-05-10 4 A $14.62 $21,243 D/D 1,453 2,824     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2021-03-05 4 OE $7.70 $8,331 D/D 1,082 37,524     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2020-12-28 4 OE $7.70 $32,086 D/D 4,167 36,442     -
  191 Records found
  1  2  3  4  5  6  7  8   
  Page 5 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us